Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Michael Vrkljan"'
Autor:
Neil W. Gibson, Patricia Beck, Andrew Cooke, Feng-Lei Sun, Vanessa Smith, Michael Vrkljan, Mark Bittner, Mark J. Mulvihill, Anthony Nigro, David M. Keane, Arlindo L. Castelhano, Cara Cesario, Julie L.C. Kan, David L. Emerson, Shannon L. Winski, Mary Srebernak, Christy Nillson
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 15:1669-1673
A series of [2-imidazol-1-yl-2-(6-alkoxy-naphthalen-2-yl)-1-methyl-ethyl]-dimethyl-amines were designed and synthesized as CYP26 inhibitors, serving as retinoic acid metabolic blocking agents (RAMBA's).
Autor:
Uday Narahari, Thomas M. Foster, Jeffrey D. Meyer, Jonathon J. Dormish, Michael Vrkljan, Mark C. Manning, William Porter, John F. Carpenter, Jack Henkin, Harold Staack
Publikováno v:
International Journal of Pharmaceutics. 134:193-201
A turbidimetric assay was used to determine the extent of thermally-induced aggregation in low molecular weight urokinase (LMW-UK). Previous work has shown that, under 60°C heat treatment, LMW-UK denatures and the unfolded protein proceeds to form s
Autor:
John F. Carpenter, Michael Vrkljan, William Porter, Harold Staack, Jack Henkin, Thomas M. Foster, Michael E. Powers, Mark C. Manning
Publikováno v:
Pharmaceutical Research. 11:1004-1008
Turbidimetric or light scattering assays can be used to determine the extent of aggregation in protein formulations. Using low molecular weight urokinase (LMW-UK) as a model protein, the effect of polymeric additives on heat-induced aggregation was e
Autor:
Jeffrey D. Meyer, Brent S. Kendrick, Michael Vrkljan, Jonathon J. Dormish, James E. Matsuura, John F. Carpenter, James R. Ruth, Mark C. Manning, Eli Sheftert
Publikováno v:
Biotechnology and bioengineering. 48(5)
Stabilization of proteins through proper formulation is an important challenge for the pharmaceutical industry. Two approaches for stabilization of proteins in solution are discussed. First, work describing the effect of additives on the thermally in